EULAR Impact of Rheumatic and Musculoskeletal Diseases Survey
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEuropean Alliance of Associations in Rheumatology
About this trial
The EULAR Impact of RMDs Survey collects first-hand information about the impact of rheumatic and musculoskeletal diseases (RMDs) among patients across and beyond Europe. Through periodic questionnaires, patients will provide information about their healthcare situation, and how the disease affects their social and occupational lives. This data will be an important resource for researchers, healthcare professionals, and patients alike, providing valuable insights into the burden of disease and helping improve the overall care for people living with these conditions.
Eligibility criteria
Qualifiers
18-year-old at time of baseline survey
Living in a EULAR country at time of baseline survey
Diagnosed with at least one RMD
Valid personal e-mail address
Disqualifiers
none
Trial design
Treatments tested in this trial
- Survey
Treatment groups
1,000 Participants
are divided into 1 treatment groupLocations
1EULAR8802, KilchbergCanton of Zurich, Switzerland
Sponsors and collaborators
European Alliance of Associations in Rheumatology
Lead sponsor
Source ClinicalTrials.gov